483 Valeant Pharmaceuticals North America May 2014

483 Valeant Pharmaceuticals North America May 2014

Jonee Mearns FDA$119.00 - Available Now

FDA investigators audited the Valeant Pharmaceuticals North America - Bridgewater, NJ, United States facility and issued 4 inspectional observations (via FDA 483) on 19 May 2014.

Product details

  • Category: Medical Devices & Rad Health
  • Number of Observations: 4
  • Inspection end: 19 May 2014
  • Location: Bridgewater, United States
  • FEI: 3010446985
Add To Cart